Showing results (521-530 of 4,366) with videos related to
Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|February 16, 2025
Stimulation of endothelin-1 production by autoantibodies present in patients with scleroderma renal crisisPinchao Wang, Dashan Wu, Zexian Gong, et al.Clinical Immunology (Orlando, Fla.)|February 13, 2025
Microbiome alterations in primary Sjögren's syndrome: Regional dysbiosis and microbiome-targeted therapeutic strategiesXujing Yuan, Jun Wang, Weiwei Wang, et al.Clinical Immunology (Orlando, Fla.)|February 21, 2025
Complement C5a and C5a receptor 1 mediates glomerular damage in focal segmental glomerulosclerosisXiao-Jie Gong, Jing Huang, Yue Shu, et al.Clinical Immunology (Orlando, Fla.)|September 1, 2024
IL-17 in skin infections and homeostasisM G García-Patiño, M C Marcial-Medina, B E Ruiz-Medina, et al.Clinical Immunology (Orlando, Fla.)|August 31, 2024
IL-6R (trans-signaling) is a key regulator of reverse cholesterol transport in lipid-laden macrophagesFatema Al-Rashed, Halemah AlSaeed, Nourah Almansour, et al.Clinical Immunology (Orlando, Fla.)|August 1, 2024
Patient subtyping analysis of baseline multi-omic data reveals distinct pre-immune states associated with antibody response to seasonal influenza vaccinationCigdem Sevim Bayrak, Christian V Forst, Drew R Jones, et al.Clinical Immunology (Orlando, Fla.)|August 14, 2024
Effect of DNA methylation at the CTLA4 gene on the clinical status of autoimmune thyroid diseasesHiroki Ohtani, Naoya Inoue, Yoshinori Iwatani, et al.Clinical Immunology (Orlando, Fla.)|June 27, 2024
Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutationsS E Detiger, D Paridaens, P G Kemps, et al.Clinical Immunology (Orlando, Fla.)|June 25, 2024
Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context mattersBill Giannakopoulos, Steven A KrilisClinical Immunology (Orlando, Fla.)|June 21, 2006
Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosisSara Huerta-Yepez, Mario Vega, Hermes Garban, et al.Pageof 437